News | November 25, 2025
Eris Lifesciences consolidates its stake in Swiss Parenterals
The proposed transaction will be effected as a share swap
The proposed transaction will be effected as a share swap
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
Net profit for the half-year rose to Rs. 410 crore from Rs. 351 crore
Organic capex during the quarter amounted to Rs. 491.1 crore, supporting ongoing business expansion initiatives
Collaboration aims to deliver rapid, lab-quality testing to communities worldwide – making precision health more accessible
Building on the Merck Foundation’s longstanding commitment to advancing access to high-quality health care, new national initiative supports grants to 11 organizations across the country
The quarter included three IPOs worth US$ 428 million and one Qualified Institutional Placement (QIP) worth US$ 88 million
The company's net income attributable to equity holders dropped to €2.80 billion from €2.82 billion last year
Takeda will make an upfront payment of $1.2 billion, which includes a $100 million equity investment in Innovent
Acquisition expands Novo Nordisk’s leadership in obesity-related comorbidities and metabolic diseases
Subscribe To Our Newsletter & Stay Updated
